The European Union (EU) and France have committed a €10.2 million investment to strengthen Nigeria’s pharmaceutical manufacturing capacity, in what officials describe as a major step towards health sovereignty and industrial transformation and boosting local pharmaceutical production. The investment, announced under the Global Gateway’s Manufacturing and Access to Vaccines, Medicines and Health Technologies (MAV+) Initiative, will fund the Quality Uplift for Advancing Local Industry in Medicine Standards (Qualimeds Nigeria) project—a 44-month programme designed to modernise local production, improve medicine quality and expand access to essential health technologies. According to the agreement signed...